Last reviewed 2026-04-23 · How we verify

beta carotene from Dunaliella algae

Bnai Zion Medical Center · Phase 3 active Small molecule

beta carotene from Dunaliella algae is a Small molecule drug developed by Bnai Zion Medical Center. It is currently in Phase 3 development for Prevention of vitamin A deficiency.

Beta carotene from Dunaliella algae is converted to vitamin A in the body, which is essential for maintaining healthy vision, immune function, and skin health.

Beta carotene from Dunaliella algae is converted to vitamin A in the body, which is essential for maintaining healthy vision, immune function, and skin health. Used for Prevention of vitamin A deficiency.

At a glance

Generic name	beta carotene from Dunaliella algae
Sponsor	Bnai Zion Medical Center
Modality	Small molecule
Therapeutic area	Nutrition, Dermatology, Ophthalmology
Phase	Phase 3

Mechanism of action

Beta carotene is a precursor to vitamin A, which plays a crucial role in the functioning of the immune system, vision, and skin health. It is converted to retinaldehyde and then to retinoic acid, which are the active forms of vitamin A. Vitamin A is essential for the proper functioning of the retina, immune system, and skin.

Approved indications

Prevention of vitamin A deficiency

Common side effects

Hypervitaminosis A

Key clinical trials

Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

beta carotene from Dunaliella algae CI brief — competitive landscape report
beta carotene from Dunaliella algae updates RSS · CI watch RSS
Bnai Zion Medical Center portfolio CI

Frequently asked questions about beta carotene from Dunaliella algae

What is beta carotene from Dunaliella algae?

beta carotene from Dunaliella algae is a Small molecule drug developed by Bnai Zion Medical Center, indicated for Prevention of vitamin A deficiency.

How does beta carotene from Dunaliella algae work?

Beta carotene from Dunaliella algae is converted to vitamin A in the body, which is essential for maintaining healthy vision, immune function, and skin health.

What is beta carotene from Dunaliella algae used for?

beta carotene from Dunaliella algae is indicated for Prevention of vitamin A deficiency.

Who makes beta carotene from Dunaliella algae?

beta carotene from Dunaliella algae is developed by Bnai Zion Medical Center (see full Bnai Zion Medical Center pipeline at /company/bnai-zion-medical-center).

What development phase is beta carotene from Dunaliella algae in?

beta carotene from Dunaliella algae is in Phase 3.

What are the side effects of beta carotene from Dunaliella algae?

Common side effects of beta carotene from Dunaliella algae include Hypervitaminosis A.

Manufacturer: Bnai Zion Medical Center — full pipeline
Therapeutic area: All drugs in Nutrition, Dermatology, Ophthalmology
Indication: Drugs for Prevention of vitamin A deficiency
Compare: beta carotene from Dunaliella algae vs similar drugs
Pricing: beta carotene from Dunaliella algae cost, discount & access